about
miR-449 inhibits cell proliferation and is down-regulated in gastric cancerThe phenotype of gastric mucosa coexisting with Barrett's oesophagusEpstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expressionLY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.Extremely well-differentiated adenocarcinoma of the stomach: clinicopathological and immunohistochemical featuresH pylori status and angiogenesis factors in human gastric carcinoma.The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac locationEpstein-Barr virus and gastric carcinomaConcurrent overexpression of serum p53 mutation related with Helicobacter pylori infection.Expression of mutant type-p53 products in H pylori-associated chronic gastritis.hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions.Gastric pathology in patients with common variable immunodeficiencyAnalysis of cell damage and proliferation in Helicobacter pylori-infected human gastric mucosa from patients with gastric adenocarcinomaAnalysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer.Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma.Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression.Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardiaMultiple simultaneous gastric carcinomas.Analysis of p53, K-ras gene mutation & Helicobacter pylori infection in patients with gastric cancer & peptic ulcer disease at a tertiary care hospital in north IndiaFluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pyloriFrequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomasImmunohistochemical Analysis of p53, Ki-67, CD44, HER-2/neu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran.Helicobacter pylori-Induced Signaling Pathways Contribute to Intestinal Metaplasia and Gastric Carcinogenesis.Detection of p53 mutations in precancerous gastric tissue.Nutlin-3, A P53-Mdm2 Antagonist For Nasopharyngeal Carcinoma Treatment.Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers.Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cellsHelicobacter, Inflammation, and Gastric Cancer.p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma.Role of p53 in the progression of gastric cancerChronology of p53 protein accumulation in gastric carcinogenesis.Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis.Apoptosis in gastric carcinomas and its association with cell proliferation and differentiation.Expression of human telomerase RNA is an early event of stomach carcinogenesis.Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric intestinal-type carcinomas in vivo.
P2860
Q21245766-9584C0DA-9F48-4718-9F4E-05C7FFC57C52Q28365932-DF3FFA88-8E1B-420A-9958-7FA1B5AEE084Q33641167-BECEA953-6ECA-460C-B5A7-FEB32DBF9FA8Q33655676-F03AB396-F95D-4FB5-8FBA-FA23C4E75F85Q33868470-E81F3AD4-4972-440E-8170-CD4F11BC46B1Q33869485-B40AEE6C-50B8-4F1B-90E0-1FB7BA88A870Q33918569-730AB68E-7750-4BE2-AA00-A687448EEE7FQ33918583-3CE9487A-944E-42F6-8045-1FF5AEF71DECQ34010863-B0AC3603-471C-4103-8438-6ECC4B325282Q34099122-1A64758D-C950-4B4D-AD90-0417B8B035A9Q34329231-5D6AD132-6E85-4318-9855-073A2ABFB2ACQ35356135-B3CA8CE4-648E-41F5-AB8E-569A451C53B6Q35763487-3F79AD51-B19E-4438-B562-84C9AC89DAFEQ35782454-BE1AB4A8-B062-4033-B71B-7B5125DC413FQ35858963-1B3282B2-89E8-4033-AE9D-740A0B85AEDAQ36121305-47199BBC-0350-414F-AEFB-2395AE8E2F75Q36136842-A2F8AF8B-8D07-4F51-B894-F23BA7AB0A26Q36190380-CC61502B-F965-41FB-BBC5-7AC5D965FF85Q36294859-86FD5B6B-DAA3-4587-AA98-6A6403A3C695Q36431577-B8D14347-0A72-49A4-A450-17B9F1B99DAEQ36450006-D8475B0E-B9A5-4152-9F83-EC16F9270E7CQ36616789-0B61816A-76F5-46CD-8B52-14DA2BDC5654Q36622364-8BC8A1AE-7E47-4E8B-B750-C410D63E20BDQ37552725-8A80A868-150B-49CA-8336-F6B7381ECBECQ38524822-18D1DCEE-3A3D-4657-B409-215D8FE152C6Q38602249-9EB1B883-B73E-446B-9374-1E46E085194EQ38656647-5B72E620-E133-45DD-BCF3-2D18EAD7ED48Q39579538-CB8798EF-AF1F-420E-A864-7068604494AAQ40623145-DC33F4DB-41E5-4216-837C-4148FF05EA18Q40760600-4EB3D73E-2B1F-4E16-925A-43D930BFA0CFQ40794448-5F760A09-5EB5-45BC-8295-A16CEC448DB4Q41773412-03FF25F2-A199-4E6C-98A1-4C9FFF71D7AEQ42005935-68E3A784-E368-468D-92C3-AD4AD50DDB19Q42276365-34434E4F-03D9-4FB3-9CC7-6520F52190BDQ43018257-59E67982-C195-400A-8CDA-44EAC4C58807Q55282611-BAF0A203-755E-4A6D-B196-8170B72E01DAQ55346573-A47B5F47-2209-4A33-A345-5336F94B7605Q55362870-BE7E989B-EF06-49AE-98C6-D92199DEBA9E
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
p53 alteration in gastric precancerous lesions.
@ast
p53 alteration in gastric precancerous lesions.
@en
type
label
p53 alteration in gastric precancerous lesions.
@ast
p53 alteration in gastric precancerous lesions.
@en
prefLabel
p53 alteration in gastric precancerous lesions.
@ast
p53 alteration in gastric precancerous lesions.
@en
P2093
P2860
P1476
p53 alteration in gastric precancerous lesions
@en
P2093
P2860
P304
P407
P577
1994-03-01T00:00:00Z